A new vaccine against malaria, a scourge especially in sub-Saharan Africa, shows that a series of three shots offers about 50 percent protection. It's one small-to-medium sized step toward a truly protective malaria vaccine, which would amount to saving many thousands of lives in the near term.
Mosquirix
The holy grail of malaria prevention, a vaccine effective in preventing this devastating mosquito-borne parasitic disease, is one step closer to reality. The new GSK vaccine, RTS/S now called Mosquirix, provided significant albeit below-ideal levels of protection for infants and toddler, which will save thousands of lives.